ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021
Inherent and modifiable risk factors for peripheral venous catheter failure during cancer treatment: a prospective cohort study.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 50 citations in OpenAlex.
- Health-related quality of life and experience measures, to assess patients' experiences of peripheral intravenous catheters: a secondary data analysis.Health and quality of life outcomes · 2024Trial
- Nurses' Involvement in the Development and Usability Assessment of an Innovative Peripheral Intravenous Catheterisation Pack: A Mix-Method Study.International journal of environmental research and public health · 2022Trial
- Beyond Bloodstream Infection: The Potential for Hierarchical Composite Endpoints in Vascular Access Research.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- Evaluation of peripheral intravenous line securement devices under clinically relevant loading and perspiratory conditions.PloS one · 2026Article
- Autoimmune Phenotype Confirmation Intervals and Clinical Indicators in Patients With Latent Autoimmune Diabetes in Adults (LADA) in Southwest China: A Multicenter Retrospective Cross-Sectional Study.Journal of diabetes research · 2026Observational
- Infection risk of peripheral intravenous catheters: meta-synthesis of 18 prospective studies with 14,606 catheters.Antimicrobial resistance and infection control · 2025Article
- Improving Peripheral Venous Puncture Outcomes in ICU via Vein Grading Management.Medical science monitor : international medical journal of experimental and clinical research · 2025Article
- Impact of Noradrenaline Administration Dosage on the Occurrence of Peripheral Intravenous Catheter-Related Venous Phlebitis in Critically Ill Patients Using a Time-Dependent Multilevel Cox Regression Model.Emergency medicine international · 2025Article
- Association between peripheral venous catheter failure and care complexity factors in emergency department: a cross-sectional study.BMJ open · 2024Article
- The Role of Nursing in the Management of Chemotherapy Extravasation: A Systematic Review Regarding Public Health.Healthcare (Basel, Switzerland) · 2024Review
- Development of a Machine Learning-Based Model for Predicting the Incidence of Peripheral Intravenous Catheter-Associated Phlebitis.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2024Article
- Risk factors associated with the occurrence of the adverse event phlebitis in hospitalized adult patients.Revista brasileira de enfermagem · 2024Review
- Article
- Prevalence and Factors Affecting Difficult Intravenous Access in Children in Oman: A Cross-sectional Study.Oman medical journal · 2022Article
- Peripheral intravenous catheters in the care of oncology and haematology patients.The Australian journal of cancer nursing · 2022Article
- Risk factors for peripheral intravascular catheter-related phlebitis in critically ill patients: analysis of 3429 catheters from 23 Japanese intensive care units.Annals of intensive care · 2022Article
- A Primer and Literature Review on Internal and External Retention Mechanisms for Catheter Fixation.Cureus · 2022Review
- Nurses' Practices in the Peripheral Intravenous Catheterization of Adult Oncology Patients: A Mix-Method Study.Journal of personalized medicine · 2022Article
- Cancer patients in Palliative Care: occurrences related to venipuncture and hypodermoclysis.Revista latino-americana de enfermagem · 2022Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
Abstract
purposeTo identify modifiable and non-modifiable risk factors for peripheral intravenous catheter (PIV) failure among patients requiring intravenous treatment for oncology and haematology conditions.
methodsA single-centre prospective cohort study was conducted between October 2017 and February 2019. Adult in-patients requiring a PIV for therapy were prospectively recruited from two cancer units at a tertiary hospital in Queensland, Australia. The primary outcome was a composite of complications leading to PIV failure (local and bloodstream infection; occlusion; infiltration/extravasation; leakage; dislodgement; and/or phlebitis). Secondary outcomes were (i) PIV dwell time; (ii) insertion and (iii) failure of a CVAD; (iv) adverse events; (v) length of hospital stay. Outcomes were investigated using Bayesian multivariable linear regression modelling and survival analysis.
resultsOf 200 participants, 396 PIVs were included. PIV failure incidence was 34.9%; the most common failure type was occlusion/infiltration (n = 74, 18.7%), then dislodgement (n = 33, 8.3%), and phlebitis (n = 30, 7.6%). While several patient and treatment risk factors were significant in univariable modelling, in the final multivariable model, only the use of non-sterile tape (external to the primary dressing) was significantly associated with decreased PIV dislodgement (hazard ratio 0.06, 95% confidence interval 0.01, 0.48; p = 0.008).
conclusionPIV failure rates among patients receiving cancer treatment are high, the sequelae of which may include delayed treatment and infection. Larger studies on risk factors and interventions to prevent PIV failure in this population are needed; however, the use of secondary securements (such as non-sterile tape) to provide further securement to the primary PIV dressing is particularly important.
trial registrationStudy methods were registered prospectively with the Australian New Zealand Clinical Trials Registry on the 27
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.